Home Newsfeeds Vertical Research Downgrades Stanley Black & Decker to Hold

Vertical Research Downgrades Stanley Black & Decker to Hold

Vertical Research analyst Jeffrey Sprague downgrades Stanley Black & Decker (NYSE:SWK) from Buy to Hold.

byBenzinga Newsdesk

July 29, 2022

1 minute read

Vertical Research analyst Jeffrey Sprague downgrades Stanley Black & Decker (NYSE:SWK) from Buy to Hold.

Legal
News

Arbutus Biopharma Announces Claim Construction Ruling In Ongoing Patent Infringement Lawsuit Against Moderna

By Benzinga Newsdesk

April 4, 8:42 AM

The following summarizes the Court's Opinion:Composition of Total Lipid (‘069)The Court agreed with Plaintiffs' position that the claimed molar percentage (mol. %) ranges can be met by any particle and is not limited to

ABUS

CENTOGENE And Evotec Announce Discovery Of New Molecule To Treat Gaucher Disease

By Benzinga Newsdesk

May 14, 8:53 AM

CENTOGENE to receive license fee providing Evotec with R&D license to complete next phase of pre-clinical researchCompanies amend existing drug discovery partnership for Evotec to lead continued development. Upon

CNTG

3 Biggest Factors For Online Travel Stocks in 2023, According to Morgan Stanley

By Anusuya Lahiri

August 23, 3:20 PM

Morgan Stanley analyst Brian Nowak highlighted that the 2Q earnings commentary failed to change the importance of the state of the consumer, namely the high-end consumer, on the forward growth for travel.

ABNB